Author: Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmans T, Ueda S, Wyse E, Yashar CM, McMillian N, Scavone J
Year: 2017
AGREE II score: Available
Developer organization: National Comprehensive Cancer Network
Type of cancer: Cervical, Gynecological
Patient population: Adult
Location: International
This is a clinical practice guideline for women with cervical cancer. The guideline examines the initial diagnosis and workup, staging, primary and adjuvant treatment, surveillance, and therapy following relapse for these patients. Treatment for metastatic disease is also discussed, as are the topics of incidental cervical cancer and the occurrence of cervical cancer in pregnant women.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 25%
Applicability: 58.3%
Stakeholder involvement: 47.2%
Editorial independence: 95.8%
Rigour: 74%
Clarity presentation: 88.9%
